Cannabics PharmaceuticalsCNBX 
$0.010.00%24h
0.00%24h
Global rank
Market cap$88.25K
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-0.02
P/S0.22
Revenue$410.17K
Earnings-$3.71M
Dividend yield-
Main Sector
Healthcare
Category
Cannabics Pharmaceuticals CNBX Operating Margins
Operating Margin in 2022: -2.27%
According to Cannabics Pharmaceuticals latest financial reports the company has an operating margin of -2.27%, an decrease of -97.70% to 2022. At the end of 2022 company had an operating margin of -98.60%.
Cannabics Pharmaceuticals Operating Margin from 2020 to 2024
-
Value:-
CNBX Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -2.27% | -97.70% |
| 2022 | -98.60% | - |
| 2020 | -425.24% | - |
View the highest operating margin companies 
